This report contains market size and forecasts of Recto-vaginal Fistula Treatment in Global, including the following market information:
Global Recto-vaginal Fistula Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Recto-vaginal Fistula Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibiotics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recto-vaginal Fistula Treatment include Pfizer, Inc., GlaxoSmithKline plc, Sanofi S.A., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc., W. L. Gore & Associates, Inc., Mount Sinai Hospital, Tubingen University Hospital and St. Mark's Hospital and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recto-vaginal Fistula Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recto-vaginal Fistula Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Recto-vaginal Fistula Treatment Market Segment Percentages, by Type, 2021 (%)
Antibiotics
Biologics Therapy
Sphincteroplasty Procedure
Endorectal Advancement Flap Procedure
Others
Global Recto-vaginal Fistula Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Recto-vaginal Fistula Treatment Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Others
Global Recto-vaginal Fistula Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Recto-vaginal Fistula Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recto-vaginal Fistula Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Recto-vaginal Fistula Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
GlaxoSmithKline plc
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Johnson & Johnson Services, Inc.
W. L. Gore & Associates, Inc.
Mount Sinai Hospital
Tubingen University Hospital
St. Mark's Hospital
Apollo Hospitals Enterprise Ltd.